Kiyatec
Business Services · South Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 N Main St, Greenville, South Carolina,...Phone Number
(864) 502-2013Website
www.kiyatec.comRevenue
$6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kiyatec
Started in 2005 and based in Greenville, South Carolina, Kiyatec is a functional precision oncology company that measures the response of each patients live cancer cells to inform oncologists treatment selection decisions. The companys Clinical Services offers clinical testing for high-grade glioma, and is developing assays for use in ovarian, breast, non-small cell lung cancers, and rare tumors in its CLIA certified lab. The companys Drug Development Services works in partnership with leading biopharmaceutical companies to unlock response dynamics for their pre-clinical investigational drug candidates across the majority of solid tumor types.Explore more
Kiyatec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kiyatec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Kiyatec launches new products
Check out if Kiyatec is spiking on competitors!
Earning: See what the market has to say on Kiyatec recently announced quarterly report
Check if Kiyatec has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Kiyatec has new funding data
Congratulate Masked Content for being promoted to Masked Content at Kiyatec
Kiyatec, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Kiyatec had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Kiyatec
Compare insights from companies similar to Kiyatec, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kiyatec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kiyatec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kiyatec.
Kiyatec financials insights
Gather financial insights about Kiyatec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$3.1M
2019
Series B
$3M
2020
Debt
$150K
2021
Debt
$278K
Private Equity
$2.5M
2022
Series C
$18M
Kiyatec Tech Stack
A closer look at the technologies used by Kiyatec
Most Recent Scoops
Person-Based
Person-Based
Lateral Move
Executive Move
Board of Directors
Promotion
Executive Move
Kiyatec News & Media
Kiyatec Announces Publication of Groundbreaking Study on 3D Predict™ Glioma in High-Grade Glioma (HGG) Patients
GREENVILLE, S.C.--(BUSINESS WIRE)--Kiyatec, leaders in functional precision oncology, today announced the publication of a pivotal study in Scientific Reports highlighting the impact of the 3D Predict Glioma test on improving survival outcomes for patients with HGG. The study, titled “Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma,” presents compelling evidence that the 3D Predict Glioma testThe End Brain Cancer Initiative Promotes Awareness of Kiyatec's 3D Predict™ Test for Personalizing Cancer Treatment
The End Brain Cancer Initiative Promotes Awareness of Kiyatec's 3D Predict™ Test for Personalizing Cancer Treatment REDMOND, WA, UNITED STATES, June 13, 2024 /EINPresswire.com/ -- Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@ …Kiyatec Appoints Eric Perreault as New CEO to Lead Strategic Expansion
GREENVILLE, S.C.--(BUSINESS WIRE)--Kiyatec, a leading biotechnology company specializing in 3D cell culture technology, is pleased to announce the promotion of Eric Perreault to the position of chief executive officer (CEO). As CEO, Eric will continue to lead Kiyatec in its mission to revolutionize cancer care by harnessing the power of functional precision medicine with its KIYA-Predict™ and 3D Predict™ platforms. He succeeds Matt Gevaert, PhD, who after more than 15 years as CEO will remain
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kiyatec
Sign Up For FreeTo access detailed company insights
Started in 2005 and based in Greenville, South Carolina, Kiyatec is a functional precision oncology company that measures the response of each patients live cancer cells to inform oncologists treatment selection decisions. The companys Clinical Services offers clinical testing for high-grade glioma, and is developing assays for use in ovarian, brea... Read More
